---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-035323"
form_type: "8-K"
ticker: "MGRX"
cik: "0001938046"
company_name: "MANGOCEUTICALS, INC."
filed_at: "2026-07-30T11:00:26+00:00"
generated_at: "2026-07-30T11:06:36.185610+00:00"
event_type: "m_and_a"
sentiment: "neutral"
materiality_score: 0.9
calibrated_materiality_score: 0.9
confidence: "high"
source: SEC EDGAR
---

# Mangoceuticals enters business combination with Nuclea Energy; Nuclea shareholders to own ~96% of combined entity

## Summary
- Nuclea shareholders will receive exchangeable shares exchangeable 1:1 for MGRX common, representing ~96% of fully diluted equity.
- Existing Mangoceuticals shareholders will hold approximately 4% of the combined company.
- Jacob Cohen to resign as CEO at closing, become President; Sagar Sanghera to become Executive Chairman, Josef Freundorfer CEO.
- Transaction requires minimum $15M PIPE financing, stockholder approval, and Nasdaq non-objection; closing expected before approvals.
- Bylaw amended to reduce quorum from majority to one-third of voting power.

## SEC filing metadata
- accession: 0001493152-26-035323
- form_type: 8-K
- ticker: MGRX
- cik: 0001938046
- company_name: MANGOCEUTICALS, INC.
- filed_at: 2026-07-30T11:00:26+00:00
- event_type: m_and_a
- sentiment: neutral
- materiality_score: 0.9
- calibrated_materiality_score: 0.9
- confidence: high
- sec_items: 1.01, 5.02, 5.03, 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1938046/000149315226035323/0001493152-26-035323-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1938046/000149315226035323/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-035323
- JSON: https://secwatch.observer/filing/0001493152-26-035323.json
- Plain text: https://secwatch.observer/filing/0001493152-26-035323.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.